Fidelity Investments’s DarioHealth DRIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-5
Closed -$67 5428
2025
Q2
$67 Buy
+5
New +$69 ﹤0.01% 5160
2024
Q3
Hold
0
-$1 5546
2024
Q2
Hold
0
5345
2023
Q3
Hold
0
-$8 5333
2023
Q2
Sell
-106
Closed -$8.05K 5288
2023
Q1
$8.72K Sell
106
-332
-76% -$32.6K ﹤0.01% 4182
2022
Q4
$37.5K Buy
438
+431
+6,157% +$38.8K ﹤0.01% 3536
2022
Q3
$1K Sell
7
-276
-98% -$29.6K ﹤0.01% 4648
2022
Q2
$35K Buy
283
+262
+1,248% +$30.7K ﹤0.01% 3689
2022
Q1
$2K Buy
21
+9
+75% +$1.49K ﹤0.01% 4643
2021
Q4
$3K Buy
+12
New +$3.65K ﹤0.01% 3913

Other funds holding DRIO

Fidelity Investments's DRIO Position: Q3 2025 in Review

Fidelity Investments sold out of DarioHealth (DRIO) in Q3 2025, closing a stake of 5 shares — an estimated $67 sold.

Fidelity Investments first reported a position in DRIO in Q4 2021 and held it in 7 quarters. The position peaked at $37.5K in Q4 2022. 23 funds tracked by Wall St. Rank hold DRIO as of Q3 2025.

  • Fidelity Investments reported no remaining DarioHealth position as of Q3 2025 after selling out during the quarter.
  • Fidelity Investments sold 5 DarioHealth shares in Q3 2025, an estimated $67.
  • Fidelity Investments first reported a position in DarioHealth in Q4 2021 and held it in 7 quarters.
  • Fidelity Investments's DarioHealth position peaked at $37.5K in Q4 2022.
  • 23 funds tracked by Wall St. Rank held DarioHealth as of Q3 2025.

Based on Fidelity Investments's 13F filing for Q3 2025, filed 13 Nov 2025.